125 related articles for article (PubMed ID: 9973597)
1. Regulation of c-met expression in B16 murine melanoma cells by melanocyte stimulating hormone.
Rusciano D; Lorenzoni P; Burger MM
J Cell Sci; 1999 Mar; 112 ( Pt 5)():623-30. PubMed ID: 9973597
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms regulating c-met overexpression in liver-metastatic B16-LS9 melanoma cells.
Elia G; Ren Y; Lorenzoni P; Zarnegar R; Burger MM; Rusciano D
J Cell Biochem; 2001; 81(3):477-87. PubMed ID: 11255230
[TBL] [Abstract][Full Text] [Related]
3. Expression of constitutively activated hepatocyte growth factor/scatter factor receptor (c-met) in B16 melanoma cells selected for enhanced liver colonization.
Rusciano D; Lorenzoni P; Burger MM
Oncogene; 1995 Nov; 11(10):1979-87. PubMed ID: 7478516
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor/scatter factor and hepatocytes are potent downregulators of tyrosinase expression in B16 melanoma cells.
Rusciano D; Lorenzoni P; Lin S; Burger MM
J Cell Biochem; 1998 Nov; 71(2):264-76. PubMed ID: 9779824
[TBL] [Abstract][Full Text] [Related]
5. Interactions between retinoic acid and protein kinase C in induction of melanoma differentiation.
Niles RM
Adv Exp Med Biol; 1994; 354():37-57. PubMed ID: 8067288
[TBL] [Abstract][Full Text] [Related]
6. Influence of hepatocyte growth factor/scatter factor on the metastatic phenotype of B16 melanoma cells.
Rusciano D; Lin S; Lorenzoni P; Casella N; Burger MM
Tumour Biol; 1998; 19(5):335-45. PubMed ID: 9701724
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of B16 murine melanoma cells is associated with an increased level of c-SRC.
O'Connor TJ; Fujita DJ
Melanoma Res; 1995 Feb; 5(1):5-13. PubMed ID: 7537564
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of retinoic acid receptor function and retinoic acid-regulated gene expression in mouse melanoma cells by calreticulin. A potential pathway for cyclic AMP regulation of retinoid action.
Desai D; Michalak M; Singh NK; Niles RM
J Biol Chem; 1996 Jun; 271(25):15153-9. PubMed ID: 8662962
[TBL] [Abstract][Full Text] [Related]
9. Differentiation and metastasis in melanoma.
Rusciano D
Crit Rev Oncog; 2000; 11(2):147-63. PubMed ID: 11005510
[TBL] [Abstract][Full Text] [Related]
10. Expression of c-Met proto-oncogene in metastatic macrophage x melanoma fusion hybrids: implication of its possible role in MSH-induced motility.
Chakraborty AK; Kolesnikova N; Sousa Jde F; Espreafico EM; Peronni KC; Pawelek J
Oncol Res; 2003; 14(3):163-74. PubMed ID: 14760865
[TBL] [Abstract][Full Text] [Related]
11. Interaction of melanin-concentrating hormone (MCH), neuropeptide E-I (NEI), neuropeptide G-E (NGE), and alpha-MSH with melanocortin and MCH receptors on mouse B16 melanoma cells.
Hintermann E; Tanner H; Talke-Messerer C; Schlumberger S; Zumsteg U; Eberle AN
J Recept Signal Transduct Res; 2001 Feb; 21(1):93-116. PubMed ID: 11693176
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the binding of MSH-B, HB-228, GHRP-6 and 153N-6 to the human melanocortin receptor subtypes.
Schiöth HB; Muceniece R; Wikberg JE
Neuropeptides; 1997 Dec; 31(6):565-71. PubMed ID: 9574823
[TBL] [Abstract][Full Text] [Related]
13. Homologous and heterologous regulation of alpha-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines.
Siegrist W; Stutz S; Eberle AN
Cancer Res; 1994 May; 54(10):2604-10. PubMed ID: 8168086
[TBL] [Abstract][Full Text] [Related]
14. The regulation of cyclic AMP production and the role of cyclic AMP in B16 melanoma cells of differing metastatic potential.
Hill SE; Rees RC; MacNeil S
Clin Exp Metastasis; 1990; 8(5):475-89. PubMed ID: 2167782
[TBL] [Abstract][Full Text] [Related]
15. Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells.
Desai SH; Boskovic G; Eastham L; Dawson M; Niles RM
Biochem Pharmacol; 2000 May; 59(10):1265-75. PubMed ID: 10736427
[TBL] [Abstract][Full Text] [Related]
16. The α-melanocyte stimulating hormone/peroxisome proliferator activated receptor-γ pathway down-regulates proliferation in melanoma cell lines.
Flori E; Rosati E; Cardinali G; Kovacs D; Bellei B; Picardo M; Maresca V
J Exp Clin Cancer Res; 2017 Oct; 36(1):142. PubMed ID: 29020973
[TBL] [Abstract][Full Text] [Related]
17. Expression of the fos oncogene in B16 melanoma cells exhibiting different metastatic abilities.
Urabe A; Nakayama J; Taniguchi S; Inoue M; Hori Y
J Dermatol Sci; 1990 Nov; 1(6):455-8. PubMed ID: 2126954
[TBL] [Abstract][Full Text] [Related]
18. Linking αMSH with PPARγ in B16-F10 melanoma.
Maresca V; Flori E; Camera E; Bellei B; Aspite N; Ludovici M; Catricalà C; Cardinali G; Picardo M
Pigment Cell Melanoma Res; 2013 Jan; 26(1):113-27. PubMed ID: 22863076
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor-induced expression of ornithine decarboxylase, c-met, and c-myc is differently affected by protein kinase inhibitors in human hepatoma cells HepG2.
Desiderio MA; Pogliaghi G; Dansi P
Exp Cell Res; 1998 Aug; 242(2):401-9. PubMed ID: 9683527
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of MET expression by alpha-melanocyte-stimulating hormone and MITF allows hepatocyte growth factor to protect melanocytes and melanoma cells from apoptosis.
Beuret L; Flori E; Denoyelle C; Bille K; Busca R; Picardo M; Bertolotto C; Ballotti R
J Biol Chem; 2007 May; 282(19):14140-7. PubMed ID: 17371876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
